Fintel reports that on July 24, 2025, Cantor Fitzgerald initiated coverage of Eupraxia Pharmaceuticals (NasdaqCM:EPRX) with a ...

Cantor Fitzgerald analyst Deepak Mathivanan maintained a Hold rating on Alphabet Class A today and set a price target of $201.00. The company’s shares opened today at $197.03. Take advantage of ...

Elon Musk warned that Tesla could face "a few rough quarters," as it weathers shifting tariffs and the end of EV tax credits ...

Cantor Fitzgerald, a company led by the sons of Howard Lutnick, has offered to buy the rights in potential refunds from ...

Bitmine to build its Ethereum holdings to $4.5 billion through a stock sale, tapping into growing institutional interest and ...

A subsidiary of Cantor Fitzgerald, which is run by the sons of US commerce secretary Howard Lutnick, is letting clients essentially bet that President Donald Trump’s tariffs will be struck down in ...

Analysts expect the Dallas, Texas-based company to report quarterly earnings at $1.33 per share, up from $1.22 per share in ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $490.55, a high estimate of $555.00, and a low estimate of $371.00. This upward trend is evident, with the ...

Discover key insights from Tenet Healthcare's Q2 2025 earnings call—strong financial performance, raised guidance, USPI growth, and increased ...

A high-level overview of Cantor Equity Partners III, Inc. (CAEP) stock. View (CAEP) real-time stock price, chart, news, analysis, analyst reviews and more.